Proteome Sciences plc (LON:PRM – Get Free Report) shot up 2.6% during trading on Monday . The company traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.15 ($0.04). 555,891 shares were traded during mid-day trading, an increase of 247% from the average session volume of 160,411 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Price Performance
The company has a market cap of £8.86 million, a PE ratio of -300.00 and a beta of 0.07. The company’s 50 day simple moving average is GBX 2.71 and its two-hundred day simple moving average is GBX 3.16.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Stories
- Five stocks we like better than Proteome Sciences
- How to Start Investing in Real Estate
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- What to Know About Investing in Penny Stocks
- CarMax Gets in Gear: Is Now the Time to Buy?
- Upcoming IPO Stock Lockup Period, Explained
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
